NHS Framework Agreement for Branded medicines - National

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£526M
Sector
HEALTH
Published
27 Apr 2023
Delivery
01 May 2022 to 30 Apr 2024
Deadline
09 Dec 2021 13:00

Concepts

Location

Geochart for 1 buyers and 86 suppliers

1 buyer

86 suppliers

Description

NHS Framework Agreement for Branded medicines - National FIND A TENDER (FTS) Reference number FTS-003607 Offer reference number CM/PHR/21/5643 NHS Framework Agreement for Branded Medicines - National Period of Framework: 1 May 2022 to 30 April 2024

Award Detail

1 Thornton & Ross (Huddersfield)
  • Value: £526,000,000
2 Selective Supplies (London)
  • Value: £526,000,000
3 Teva (Wakefield)
  • Value: £526,000,000
4 Wockhardt (Wrexham)
  • Value: £526,000,000
5 Martindale Pharma (None)
  • Value: £526,000,000
6 Thea Pharmaceuticals (Newcastle)
  • Value: £526,000,000
7 Merck Sharpe & Dohme (London)
  • Value: £526,000,000
8 Norgine Pharmaceuticals (Uxbridge)
  • Value: £526,000,000
9 Kent Pharma (Heathrow)
  • Value: £526,000,000
10 Tillomed Laboratories (Luton)
  • Value: £526,000,000
11 Bayer (Reading)
  • Value: £526,000,000
12 Roche Products (Garden City)
  • Value: £526,000,000
13 Dexcel Pharma (Daventry)
  • Value: £526,000,000
14 Mylan (Barnet)
  • Value: £526,000,000
15 Abbvie (Maidenhead)
  • Value: £526,000,000
16 Rosemont Pharmaceuticals (Leeds)
  • Value: £526,000,000
17 Recordati Rare Diseases (Bracknell)
  • Value: £526,000,000
18 Intrapharm Laboratories (Maidenhead)
  • Value: £526,000,000
19 Accord (None)
  • Value: £526,000,000
20 Ranbaxy (Hayes)
  • Value: £526,000,000
21 Glaxosmithkline (London)
  • Value: £526,000,000
22 Drugsrus (Northwood)
  • Value: £526,000,000
23 Sandoz (Camberley)
  • Value: £526,000,000
24 Ennogen Healthcare (Dartford)
  • Value: £526,000,000
25 Mibe Pharma (London)
  • Value: £526,000,000
26 Cambridge Healthcare Supplies (None)
  • Value: £526,000,000
27 Morningside Pharmaeuticals (Northampton)
  • Value: £526,000,000
28 Pfizer (None)
  • Value: £526,000,000
29 DR Falk Pharma (None)
  • Value: £526,000,000
30 Mercury Pharmaceuticals (London)
  • Value: £526,000,000
31 Fresenius Kabi (None)
  • Value: £526,000,000
32 Novo Nordisk (Gatwick)
  • Value: £526,000,000
33 Neon Healthcare (None)
  • Value: £526,000,000
34 Tillotts Pharma (None)
  • Value: £526,000,000
35 Napp Pharmaceuticals (Cambridge)
  • Value: £526,000,000
36 Takeda (London)
  • Value: £526,000,000
37 Day Lewis Medical (None)
  • Value: £526,000,000
38 B Braun Medical (Sheffield)
  • Value: £526,000,000
39 Aguettant (Bristol)
  • Value: £526,000,000
40 Ferring Pharmaceuticals (West Drayton)
  • Value: £526,000,000
41 Aventis Pharma (Reading)
  • Value: £526,000,000
42 Astrazeneca (Luton)
  • Value: £526,000,000
43 Baxter Healthcare (None)
  • Value: £526,000,000
44 Colonis Pharma (London)
  • Value: £526,000,000
45 Eli Lilly (Basingstoke)
  • Value: £526,000,000
46 Reckitt Benckiser (None)
  • Value: £526,000,000
47 Crescent Pharma (None)
  • Value: £526,000,000
48 CST Pharma (Walsall)
  • Value: £526,000,000
49 Janssen Cilag (Highwycombe)
  • Value: £526,000,000
50 Grunenthal (Stockenchurch)
  • Value: £526,000,000
51 Aspire Pharma (None)
  • Value: £526,000,000
52 Flynn Pharma (None)
  • Value: £526,000,000
53 Chiesi (Manchester)
  • Value: £526,000,000
54 Ferndale Pharmaceuticals (Wetherby)
  • Value: £526,000,000
55 Logixx Pharma (None)
  • Value: £526,000,000
56 Clinigen Healthcare (Burton on Trent)
  • Value: £526,000,000
57 Aop Orphan (None)
  • Value: £526,000,000
58 Aspen Pharmacare (None)
  • Value: £526,000,000
59 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £526,000,000
60 Organon Pharmaceuticals (London)
  • Value: £526,000,000
61 Zentiva Pharma (London)
  • Value: £526,000,000
62 Orphalan (Birkirkara)
  • Value: £526,000,000
63 Fontus Health (Walsall)
  • Value: £526,000,000
64 Univar Solutions (Rotterdam)
  • Value: £526,000,000
65 Roma Pharmaceuticals (Burton upon Trent)
  • Value: £526,000,000
66 Alliance Pharmaceuticals (None)
  • Value: £526,000,000
67 Lupin Healthcare (None)
  • Value: £526,000,000
68 Cenote Pharma (None)
  • Value: £526,000,000
69 Kyowa Kirin (Galashiels)
  • Value: £526,000,000
70 Biofrontera Pharma (Leverkusen)
  • Value: £526,000,000
71 Pharmacosmos (Reading)
  • Value: £526,000,000
72 Pari (London)
  • Value: £526,000,000
73 Stirling Anglian Pharmaceuticals (Glasgow)
  • Value: £526,000,000
74 Strides Pharma (Watford)
  • Value: £526,000,000
75 Karo Pharma (Stockholm)
  • Value: £526,000,000
76 Rayner Surgical Group (Worthing)
  • Value: £526,000,000
77 Galen (Craigavon)
  • Value: £526,000,000
78 Oralieve (Luton)
  • Value: £526,000,000
79 Typharm (Norwich)
  • Value: £526,000,000
80 Opella Healthcare (None)
  • Value: £526,000,000
81 Torrent Pharma (Crawley)
  • Value: £526,000,000
82 Necessity Supplies (Northolt)
  • Value: £526,000,000
83 Focus Pharmaceuticals (London)
  • Value: £526,000,000
84 Eisai (Hatfield)
  • Value: £526,000,000
85 Cipla (None)
  • Value: £526,000,000
86 Ever Pharma (Banbury)
  • Value: £526,000,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

03. Framework Agreement and Terms and Conditions 03. Framework Agreement and Terms and Conditions.docx 220523 Branded Transparency Award Schedule 220523 Branded Transparency Award Schedule.pdf Document No.10 - Participating Authorities Document No.10 - Participating Authorities.xls 211103 - V2 -FTS-003607 Contract Notice 211103 - V2 -FTS-003607 Contract Notice.pdf Parties Appointed to the Framework - CM_PHR_21_5643 National Proprietary Medicines Framework - Copy Parties Appointed to the Framework - CM_PHR_21_5643 National Proprietary Medicines Framework - Copy.xlsx

Reference

Domains